Research Highlights: Cephalosporin use in penicillin allergyReview evaluates literature pertaining to cross-reactivity between penicillins and cephalosporins. Clinical Notes: Canadian RA guidelines address drug safety concernsNew recommendations focus on the safety of traditional and biologic disease-modifying antirheumatic drugs New Canadian guidelines for fibromyalgia management Document incorporates new evidence concerning pathogenesis, more diverse treatment strategies. Cymbalta now indicated for managing chronic OA knee pain This is the sixth Health Canada-approved indication for Cymbalta. Canadian rheumatoid arthritis guidelines address specific drug safety concerns Document addresses several specific safety concerns related to the use of traditional and biologic DMARDs in patients. Cancer rates four times higher in juvenile arthritis But use of TNF inhibitors not to blame, researcher says Autoimmune disease raises pulmonary embolism risk Anticoagulants could be warranted, Swedish researchers suggest Timing of biologics cut-off for surgery requires study Rheumatoid arthritis treatment is typically being stopped weeks before procedure despite half-lives of drugs being much shorter Biologics have lasting power in rheumatoid arthritis But recommended starting dose is not effective, Canadian researcher notes Anti-TNF agents similarly effective in rheumatoid arthritis First Previous 16 17 18 19 20 Next Last
